Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Dynavax Technologies Corporation
DYF1Current price
12.28 EUR
-0.085 EUR (-0.69%)
Last closed
13.39 USD
Company
www.dynavax.com
ISIN
US2681582019
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Frankfurt Exchange
Capitalization
1 795 675 264 USD
Yield for 12 month
-9.76 %
1Y
3Y
5Y
10Y
15Y
DYF1
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California. Address: 2100 Powell Street, EmeryVille, CA, United States, 94608
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
24.5 USDP/E ratio
105.0769Dividend Yield
–Current Year
+232 284 000 USD
Last Year
+722 683 000 USD
Current Quarter
+79 345 000 USD
Last Quarter
+73 795 000 USD
Current Year
+182 117 000 USD
Last Year
+460 530 000 USD
Current Quarter
+66 261 000 USD
Last Quarter
+61 810 000 USD
Key Figures DYF1
1 year
3 years
5 years
10 years
EBITDA
-1 623 000 USD
Operating Margin TTM
PE Ratio
105.0769
Return On Assets TTM
-0.38 %
PEG Ratio
–
Return On Equity TTM
3.18 %
Wall Street Target Price
24.5 USD
Revenue TTM
260 810 000 USD
Book Value
5.19 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
16 %
Dividend Yield
–
Gross Profit TTM
448 218 000 USD
Earnings per share
0.13 USD
Diluted Eps TTM
0.13 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
20.8 %
Profit Margin
7.85 %
Dividend Analytics DYF1
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DYF1
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
10.11.2014
Dividend Date
–
Stock Valuation DYF1
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
105.0769
Forward PE
64.9351
Enterprise Value Revenue
4.9074
Price Sales TTM
6.885
Enterprise Value EBITDA
37.0624
Price Book MRQ
2.6604
Financials DYF1
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DYF1
For 52 weeks
9.74 USD
15.01 USD
50 Day MA
11.16 USD
Shares Short Prior Month
17 043 685
200 Day MA
11.6 USD
Short Ratio
10.53
Shares Short
17 059 789
Short Percent
15.91 %
BeatStart